HARRINGTON, R. A., MARCHANT, K., KLEIMAN, N. S., LEIMBERGER, J. D., TCHENG, J. E., SIGMON, K. N., … CALIFF, R. M. (1994). BLEEDING ASSOCIATED WITH USE OF A PLATELET GLYCOPROTEIN IIBIIA INHIBITOR DURING ROUTINE CORONARY ANGIOPLASTY - IS TOO MUCH HEPARIN THE CULPRIT. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, A106–A106.

HARRINGTON, R. A., K. MARCHANT, N. S. KLEIMAN, J. D. LEIMBERGER, J. E. TCHENG, K. N. SIGMON, D. D. SMITH, M. KITT, E. J. TOPOL, and R. M. CALIFF. “BLEEDING ASSOCIATED WITH USE OF A PLATELET GLYCOPROTEIN IIBIIA INHIBITOR DURING ROUTINE CORONARY ANGIOPLASTY - IS TOO MUCH HEPARIN THE CULPRIT.” JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, February 1, 1994, A106–A106.

HARRINGTON RA, MARCHANT K, KLEIMAN NS, LEIMBERGER JD, TCHENG JE, SIGMON KN, et al. BLEEDING ASSOCIATED WITH USE OF A PLATELET GLYCOPROTEIN IIBIIA INHIBITOR DURING ROUTINE CORONARY ANGIOPLASTY - IS TOO MUCH HEPARIN THE CULPRIT. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 1994 Feb 1;A106–A106.

HARRINGTON, R. A., et al. “BLEEDING ASSOCIATED WITH USE OF A PLATELET GLYCOPROTEIN IIBIIA INHIBITOR DURING ROUTINE CORONARY ANGIOPLASTY - IS TOO MUCH HEPARIN THE CULPRIT.” JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, ELSEVIER SCIENCE INC, Feb. 1994, pp. A106–A106.

HARRINGTON RA, MARCHANT K, KLEIMAN NS, LEIMBERGER JD, TCHENG JE, SIGMON KN, SMITH DD, KITT M, TOPOL EJ, CALIFF RM. BLEEDING ASSOCIATED WITH USE OF A PLATELET GLYCOPROTEIN IIBIIA INHIBITOR DURING ROUTINE CORONARY ANGIOPLASTY - IS TOO MUCH HEPARIN THE CULPRIT. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. ELSEVIER SCIENCE INC; 1994 Feb 1;A106–A106.